DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer. Feng S, Huang Q, Deng J, Jia W, et al. Cancer Lett 2022;532:215588.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feng S, Huang Q, Deng J, Jia W, et al. DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer. Cancer Lett 2022;532:215588.
PMID: 35150809